Education
About Us
Working with TipRanks
Follow Us
Vicarious Surgical (RBOT)
NYSE:RBOT
RBOT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.27 - $19.00
Previous CloseN/A
Volume30.88K
Average Volume (3M)41.59K
Market Cap
$45.84M
Enterprise Value-$13.29M
Total Cash (Recent Filing)$9.74M
Total Debt (Recent Filing)$13.79M
Price to Earnings (P/E)―
Beta2.99
Next Earnings
May 12, 2025EPS Estimate
-2.48Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-7.94
Shares Outstanding5,276,612
10 Day Avg. Volume21,214
30 Day Avg. Volume41,592
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.29
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.21
Forecast
1Y Price Target
$10.75Price Target Upside46.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
---
Vicarious Surgical News
PremiumCompany Announcements
Vicarious Surgical’s Earnings Call: Achievements and Challenges
PremiumCompany Announcements
Vicarious Surgical Reports 2024 Financial Results and Progress---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceRBOT continues to manage its cash position responsibly, with cash management remaining a key priority ahead of key milestones for its robotic platform.
Market OutlookThe new price target of $13 reflects a positive outlook, increasing from the previous target of $10, based on future sales estimates and a discount rate.
Product DevelopmentRBOT is taking positive steps toward treating its first clinical patient.
Bears Say
Development DelaysDevelopment milestones and timelines were shifted back 3 to 6 months due to supplier dynamics which have limited key parts within the Vicarious System.
Financial NeedsThe company will need to either reduce cash burn or find some sources of non-dilutive financing.
Leadership ChallengesThe CFO departure is seen as another challenge for RBOT to handle on its path towards gaining clearance.
---
Ownership Overview
48.77% Insiders
3.74% Mutual Funds
28.97% Other Institutional Investors
15.56% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
RBOT FAQ
What was Vicarious Surgical’s price range in the past 12 months?
Vicarious Surgical lowest stock price was $4.27 and its highest was $19.00 in the past 12 months.
What is Vicarious Surgical’s market cap?
Vicarious Surgical’s market cap is $45.84M.
When is Vicarious Surgical’s upcoming earnings report date?
Vicarious Surgical’s upcoming earnings report date is May 12, 2025 which is in 47 days.
How were Vicarious Surgical’s earnings last quarter?
Vicarious Surgical released its earnings results on Mar 17, 2025. The company reported -$2.43 earnings per share for the quarter, beating the consensus estimate of -$2.689 by $0.259.
Is Vicarious Surgical overvalued?
According to Wall Street analysts Vicarious Surgical’s price is currently Undervalued.
Does Vicarious Surgical pay dividends?
Vicarious Surgical does not currently pay dividends.
What is Vicarious Surgical’s EPS estimate?
Vicarious Surgical’s EPS estimate is -2.48.
How many shares outstanding does Vicarious Surgical have?
Vicarious Surgical has 5,276,612 shares outstanding.
What happened to Vicarious Surgical’s price movement after its last earnings report?
Vicarious Surgical reported an EPS of -$2.43 in its last earnings report, beating expectations of -$2.689. Following the earnings report the stock price went down -14.849%.
Which hedge fund is a major shareholder of Vicarious Surgical?
Currently, no hedge funds are holding shares in RBOT
---
Vicarious Surgical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.75 (46.86% Upside)
$10.75 (46.86% Upside)
Insider Transactions
Sold Shares
Worth $41.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 11.2%
Last 30 Days ▼ 11.2%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-21.39%
12-Months-Change
Fundamentals
Return on Equity
-87.40%
Trailing 12-Months
Asset Growth
-43.50%
Trailing 12-Months
Company Description
Vicarious Surgical
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
---
RBOT Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive developments and challenges. While the company made significant strides in system integration, partnership expansions, and cost management, they also faced supply chain issues that have delayed clinical trials. The sentiment is balanced with strong achievements countered by notable delays.Read More>---
RBOT Stock 12 Month Forecast
Average Price Target
$10.75
▲(46.86% Upside)
Technical Analysis
Best Analysts Covering RBOT
1 Year
1 Year Success Rate
2/7 ratings generated profit
1 Year Average Return
-2.10%
reiterated a buy rating 10 days ago
Copying Josh Jennings's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -2.10% per trade.
---